Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-24

Clinical Trial Update: Radiosensitizing Effect of Nelfinavir in Locally Advanced Carcinoma of Cervix [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating nelfinavir as a radiosensitizer for locally advanced cervical cancer has completed. The update indicates completion of the study, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nelfinavir (nelfinavir)

Snippet

Sponsor: Tata Memorial Hospital | Conditions: Carcinoma Cervix,Stage III | Phase 3 | Status: COMPLETED